BCACP key terms

A patient-centered service in which the pharmacist assesses every medication a patient takes, identifies drug therapy problems, builds a care plan with the patient, and monitors outcomes over time.

A structured, often payer-sponsored program offering medication review, counseling, and care coordination to patients with multiple chronic conditions, high drug costs, or frequent care transitions.

A formal comparison of a patient's current medication list with prior lists and new orders at transitions of care, intended to catch omissions, duplications, and dosing errors.

A systematic review of each medical condition and each medication to judge whether therapy is indicated, effective, and safe and whether the patient is adherent, yielding prioritized drug therapy problems.

Measuring serum drug concentrations for agents with narrow therapeutic ranges or unpredictable pharmacokinetics, then adjusting the dose so exposure stays inside the window that balances benefit and toxicity.

A drug property in which small changes in dose or blood concentration cause clinically important changes in efficacy or toxicity, demanding careful titration, monitoring, and caution when products are substituted.

The number of patients who must receive an intervention for one additional person to benefit over a stated period; the reciprocal of the absolute risk reduction.

A conversation in which clinician and patient exchange evidence and preferences and jointly choose a plan that fits the patient's goals, values, and circumstances.

A directive, patient-centered counseling style using open questions, reflective listening, and affirmation to strengthen a patient's own reasons and confidence for changing behavior.

The degree to which a patient starts, continues, and correctly takes a prescribed medicine, including timing and dose; assessed through refill records, pill counts, or self-report.

The planned, supervised reduction or discontinuation of medications when harms outweigh benefits, such as with falls risk, limited life expectancy, or changed treatment goals.

A regularly updated expert list of medications that are potentially inappropriate for older adults, organized by drug and concern, used to prompt review rather than as an absolute prohibition.

Failure to start or intensify treatment when a measured target such as blood pressure or glucose remains above goal despite appropriate options being available.

Systematically developed recommendations from a professional or governmental body that translate evidence about a condition into guidance for clinicians, usually graded by strength of evidence.

A written protocol allowing a pharmacist to initiate, adjust, or stop drug therapy under defined conditions in partnership with a prescriber, specifying scope, documentation, and communication.

The process by which an organization verifies a clinician's license and training, then formally authorizes that person to deliver specific services within that setting.

A Medicare arrangement in which services provided by auxiliary personnel such as pharmacists are billed under a supervising practitioner's identifier when supervision and established-plan requirements are satisfied.

A federal program requiring manufacturers to sell outpatient drugs at reduced prices to eligible covered entities serving low-income patients, with rules on patient eligibility and duplicate discounts.

A quality-improvement method that compares actual prescribing, dispensing, or monitoring against agreed criteria and then acts on the gaps identified.

The continually maintained list of medications approved for use by a health system or plan, set by a committee weighing efficacy, safety, and cost, with a process for exceptions.

A rapid small-scale test of a change: plan it, run it, study results against predictions, then adopt, adapt, or abandon before spreading it more widely.

A financial ratio comparing net benefit with the cost of a program or service, used to justify pharmacist staffing, new services, or technology investments.

A data-driven approach that stratifies a defined patient group by risk and delivers proactive, coordinated interventions to improve outcomes and control costs across the whole group.

The conditions where people live, work, and receive care, such as income, housing, food access, and transportation, that shape health outcomes and the ability to take medicines.

The degree to which a person can find, understand, and use basic health information to make decisions, including reading a label or following dosing instructions.

Sensitivity is the share of people with disease whom a test correctly identifies; specificity is the share without disease correctly labeled negative. Both are independent of how common the disease is.

Incidence measures new cases arising in a population over a period; prevalence measures all existing cases at a point in time, reflecting both incidence and how long people survive with the condition.

Preventable differences in health outcomes, access, or quality between groups defined by race, ethnicity, income, geography, or other social factors, considered unjust rather than inevitable.

Indirect protection that arises when enough people in a community are immune that transmission chains break, lowering exposure risk for those who are unvaccinated or cannot respond to vaccines.

Delivery and payment models that reward quality, outcomes, and cost efficiency instead of service volume, often through shared savings, bundles, or risk-sharing contracts.

A standardized set of performance measures used by health plans to compare care quality, such as rates of medication adherence or recommended therapy in chronic disease.

Public health strategies that lower the harms of risky behavior without demanding abstinence, such as naloxone distribution, syringe services, or safer-use education.

A self-directed, outcomes-focused approach to lifelong learning in which pharmacists identify gaps, plan and complete learning, apply it, and evaluate the effect on their practice.

Supervising and teaching pharmacy learners during experiential training, including setting expectations, modeling practice, giving feedback, and documenting progress toward required competencies.

A developmental relationship in which a more experienced professional offers guidance, feedback, and sponsorship to support another person's growth, confidence, and career progression.

A leadership style that builds shared vision, stimulates new thinking, and attends to each team member's development, motivating people to commit beyond expected performance.

The ability to notice and manage one's own emotions and to read and respond to others' feelings, supporting teamwork, conflict resolution, and clear communication under pressure.

Structured methods for guiding a team or organization through a planned change, such as creating urgency, communicating a vision, removing barriers, and locking in new practices.

Actions that influence policy, systems, or resources on behalf of patients and the profession, such as educating legislators, joining coalitions, or testifying on proposed rules.